CO5150195A1 - Androgenos novedosos - Google Patents

Androgenos novedosos

Info

Publication number
CO5150195A1
CO5150195A1 CO00016933A CO00016933A CO5150195A1 CO 5150195 A1 CO5150195 A1 CO 5150195A1 CO 00016933 A CO00016933 A CO 00016933A CO 00016933 A CO00016933 A CO 00016933A CO 5150195 A1 CO5150195 A1 CO 5150195A1
Authority
CO
Colombia
Prior art keywords
androgens
new
ester
steroid
atom
Prior art date
Application number
CO00016933A
Other languages
English (en)
Inventor
Janjozef Loozen Hubert
Dirk Leysen
Van Der Louw Jaap
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5150195A1 publication Critical patent/CO5150195A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un compuesto de esteroides, o una sal o éster de él farmacéuticamente aceptable o éster, CARACTERIZADO porque posee una mitad de hidroximetilo en el átomo de carbono número 17 y una configuración 14ß, 17a para uso como medicina, con la condición de que el átomo de carbono número 11 de la estructura de esteroides no transporta, como substituto, un grupo arilo homocíclico o heterocíclico.<EMI FILE="00016933_1" ID="1" IMF=JPEG >
CO00016933A 1999-03-08 2000-03-08 Androgenos novedosos CO5150195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200665 1999-03-08

Publications (1)

Publication Number Publication Date
CO5150195A1 true CO5150195A1 (es) 2002-04-29

Family

ID=8239953

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00016933A CO5150195A1 (es) 1999-03-08 2000-03-08 Androgenos novedosos

Country Status (11)

Country Link
US (1) US6881728B1 (es)
EP (1) EP1163259B1 (es)
JP (1) JP4749550B2 (es)
AR (1) AR022852A1 (es)
AT (1) ATE228143T1 (es)
AU (1) AU3162200A (es)
CA (1) CA2359218A1 (es)
CO (1) CO5150195A1 (es)
DE (1) DE60000826T2 (es)
PE (1) PE20001489A1 (es)
WO (1) WO2000053619A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149424A (en) 1999-12-02 2007-05-15 Organon Nv Androgens are converted to methylene at positions 15,14
IL156175A0 (en) * 2000-12-11 2003-12-23 Akzo Nobel Nv Methylene steroids as novel androgens
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
TWI221154B (en) * 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USB337823I5 (es) * 1959-09-25 1976-03-23
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
US6180682B1 (en) * 1999-01-26 2001-01-30 Virgil A. Place Buccal drug delivery system for use in male contraception

Also Published As

Publication number Publication date
ATE228143T1 (de) 2002-12-15
US6881728B1 (en) 2005-04-19
PE20001489A1 (es) 2000-12-29
DE60000826D1 (de) 2003-01-02
JP2002539135A (ja) 2002-11-19
EP1163259B1 (en) 2002-11-20
AU3162200A (en) 2000-09-28
WO2000053619A1 (en) 2000-09-14
JP4749550B2 (ja) 2011-08-17
DE60000826T2 (de) 2003-04-10
CA2359218A1 (en) 2000-09-14
AR022852A1 (es) 2002-09-04
EP1163259A1 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
CO5271657A1 (es) Derivados de azaindol
CO5271716A1 (es) Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
ATE432986T1 (de) Menschlicher rezeptor für tumor necrosis factor
CO5070656A1 (es) Analogos de la rapamicina que contienen tetrazol con perio- dos de vida media mas cortos
NO20055253L (no) Behandling av autoimmun sykdom i en pasient med utilstrekkelig respons pa en TNF-alfa-inhibitor
DK0907652T3 (da) Immunosuppressive forbindelser og fremgangsmåder
PA8623601A1 (es) Protector para punta de aguja
AR005706A1 (es) Inhibidores egfr de 4-aminoquinzolina, procedimiento para su obtencion, composicion farmaceutica que los contiene, uso de los mismos para lapreparacion de un medicamento util como agente antineoplasico
CO5210886A1 (es) Aplicacion de compuestos de imidazolidin-2, 4-diona susti- tuida como antalgicos
AR045937A1 (es) Modulacion de la expresion del factor de iniciacion eucariotico eif4e
NO20011274L (no) Flashlagergruppe med indre oppfriskning
CO5271724A1 (es) Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotencia
BR0014244B1 (pt) composição aquosa para uso em restaurar a permeabilidade de uma formação contendo petróleo subterráneo.
CO5150195A1 (es) Androgenos novedosos
DE60033382D1 (de) Dateiverwaltungssystem
PT1294732E (pt) Compostos de rutenio (ii) para utilizacao na terapia do cancro
CO5271732A1 (es) Mecanismo estable de propulsar / repeler
AR031010A1 (es) Una composicion farmaceutica, util para inhibir el dano celular
ES2186153T3 (es) Sulfato de 5-alfa-pregnan-3-beta-ol-20-ona para el tratamiento de tumores y de los trastornos del snc.
AR028589A1 (es) PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE BIFENILO Y PROCEDIMIENTO PARA REDUCIR EL NIVEL DE DíMERO AQUIRAL EN LOS COMPUESTOS DE BIFENILO PREPARADOS
CO5221125A1 (es) Inhibidor de intercambiador de sodio hidrogeno de tipo 1
CO5160316A1 (es) N-oxidos de las correspondientes bases libres inhibidoras de la fosfodiesterasa iv y su uso para el tratamiento de enfer- medades inflamatorias
CO5271714A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrogeno
CO5440228A1 (es) Tratamiento de la incontinencia urinaria
Armstrong A bioarchaeological examination of the Korell-Bordeaux site (48GO54)